Filter News
Area of Research
- (-) Nuclear Science and Technology (4)
- Advanced Manufacturing (2)
- Biology and Environment (13)
- Clean Energy (53)
- Computational Biology (1)
- Computational Engineering (2)
- Computer Science (5)
- Fusion and Fission (12)
- Fusion Energy (9)
- Isotopes (3)
- Materials (22)
- Materials for Computing (6)
- National Security (11)
- Neutron Science (13)
- Sensors and Controls (1)
- Supercomputing (24)
- Transportation Systems (2)
News Topics
- (-) Biomedical (2)
- (-) Fusion (2)
- 3-D Printing/Advanced Manufacturing (2)
- Advanced Reactors (6)
- Bioenergy (1)
- Computer Science (1)
- Decarbonization (1)
- Isotopes (3)
- Materials Science (1)
- Molten Salt (3)
- Neutron Science (3)
- Nuclear Energy (17)
- Physics (1)
- Space Exploration (4)
- Sustainable Energy (1)
- Transformational Challenge Reactor (1)
Media Contacts
Juergen Rapp, a distinguished R&D staff scientist in ORNL’s Fusion Energy Division in the Nuclear Science and Engineering Directorate, has been named a fellow of the American Nuclear Society
Oak Ridge National Laboratory researchers have discovered a better way to separate actinium-227, a rare isotope essential for an FDA-approved cancer treatment.
As scientists study approaches to best sustain a fusion reactor, a team led by Oak Ridge National Laboratory investigated injecting shattered argon pellets into a super-hot plasma, when needed, to protect the reactor’s interior wall from high-energy runaway electrons.
The Department of Energy’s Oak Ridge National Laboratory is now producing actinium-227 (Ac-227) to meet projected demand for a highly effective cancer drug through a 10-year contract between the U.S. DOE Isotope Program and Bayer.